Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

59 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Targeting the Noradrenergic System in Posttraumatic Stress Disorder: A Systematic Review and Meta-Analysis of Prazosin Trials.
De Berardis D, Marini S, Serroni N, Iasevoli F, Tomasetti C, de Bartolomeis A, Mazza M, Tempesta D, Valchera A, Fornaro M, Pompili M, Sepede G, Vellante F, Orsolini L, Martinotti G, Di Giannantonio M. De Berardis D, et al. Among authors: vellante f. Curr Drug Targets. 2015;16(10):1094-106. doi: 10.2174/1389450116666150506114108. Curr Drug Targets. 2015. PMID: 25944011 Review.
Current and Future Perspectives on the Major Depressive Disorder: Focus on the New Multimodal Antidepressant Vortioxetine.
Orsolini L, Tomasetti C, Valchera A, Iasevoli F, Buonaguro EF, Fornaro M, Fiengo ALC, Martinotti G, Vellante F, Matarazzo I, Vecchiotti R, Perna G, Di Nicola M, Carano A, Di Bartolomeis A, De Giannantonio M, De Berardis D. Orsolini L, et al. Among authors: vellante f. CNS Neurol Disord Drug Targets. 2017;16(1):65-92. doi: 10.2174/1871527315666161025140111. CNS Neurol Disord Drug Targets. 2017. PMID: 27781949 Review.
Inflammatory markers and suicidal attempts in depressed patients: A review.
Marini S, Vellante F, Matarazzo I, De Berardis D, Serroni N, Gianfelice D, Olivieri L, Di Renzo F, Di Marco A, Fornaro M, Orsolini L, Valchera A, Iasevoli F, Mazza M, Perna G, Martinotti G, Di Giannantonio M. Marini S, et al. Among authors: vellante f. Int J Immunopathol Pharmacol. 2016 Dec;29(4):583-594. doi: 10.1177/0394632015623793. Epub 2016 Jan 4. Int J Immunopathol Pharmacol. 2016. PMID: 26729403 Free PMC article. Review.
New advances in the treatment of generalized anxiety disorder: the multimodal antidepressant vortioxetine.
Orsolini L, Tomasetti C, Valchera A, Iasevoli F, Buonaguro EF, Vellante F, Fornaro M, Fiengo A, Mazza M, Vecchiotti R, Perna G, de Bartolomeis A, Martinotti G, Di Giannantonio M, De Berardis D. Orsolini L, et al. Among authors: vellante f. Expert Rev Neurother. 2016 May;16(5):483-95. doi: 10.1586/14737175.2016.1173545. Epub 2016 Apr 18. Expert Rev Neurother. 2016. PMID: 27050932 Review.
The Novel Antipsychotic Cariprazine (RGH-188): State-of-the-Art in the Treatment of Psychiatric Disorders.
De Berardis D, Orsolini L, Iasevoli F, Prinzivalli E, de Bartolomeis A, Serroni N, Mazza M, Valchera A, Fornaro M, Vecchiotti R, Carano A, Sepede G, Vellante F, Matarazzo I, Pompili M, Perna G, Conti C, Segura-García C, Martinotti G, Di Giannantonio M. De Berardis D, et al. Among authors: vellante f. Curr Pharm Des. 2016;22(33):5144-5162. doi: 10.2174/1381612822666160701084447. Curr Pharm Des. 2016. PMID: 27396597 Review.
Celecoxib Adjunctive Treatment to Antipsychotics in Schizophrenia: A Review of Randomized Clinical Add-On Trials.
Marini S, De Berardis D, Vellante F, Santacroce R, Orsolini L, Valchera A, Girinelli G, Carano A, Fornaro M, Gambi F, Martinotti G, Di Giannantonio M. Marini S, et al. Among authors: vellante f. Mediators Inflamm. 2016;2016:3476240. doi: 10.1155/2016/3476240. Epub 2016 Jul 25. Mediators Inflamm. 2016. PMID: 27524864 Free PMC article. Review.
Effect of agomelatine treatment on C-reactive protein levels in patients with major depressive disorder: an exploratory study in "real-world," everyday clinical practice.
De Berardis D, Fornaro M, Orsolini L, Iasevoli F, Tomasetti C, de Bartolomeis A, Serroni N, De Lauretis I, Girinelli G, Mazza M, Valchera A, Carano A, Vellante F, Matarazzo I, Perna G, Martinotti G, Di Giannantonio M. De Berardis D, et al. Among authors: vellante f. CNS Spectr. 2017 Aug;22(4):342-347. doi: 10.1017/S1092852916000572. Epub 2016 Oct 5. CNS Spectr. 2017. PMID: 27702411
The Role of Inhaled Loxapine in the Treatment of Acute Agitation in Patients with Psychiatric Disorders: A Clinical Review.
de Berardis D, Fornaro M, Orsolini L, Iasevoli F, Tomasetti C, de Bartolomeis A, Serroni N, Valchera A, Carano A, Vellante F, Marini S, Piersanti M, Perna G, Martinotti G, Di Giannantonio M. de Berardis D, et al. Among authors: vellante f. Int J Mol Sci. 2017 Feb 8;18(2):349. doi: 10.3390/ijms18020349. Int J Mol Sci. 2017. PMID: 28208695 Free PMC article. Review.
Creativity and psychiatric illness: A functional perspective beyond chaos.
Vellante F, Sarchione F, Ebisch SJH, Salone A, Orsolini L, Marini S, Valchera A, Fornaro M, Carano A, Iasevoli F, Martinotti G, De Berardis D, Di Giannantonio M. Vellante F, et al. Prog Neuropsychopharmacol Biol Psychiatry. 2018 Jan 3;80(Pt B):91-100. doi: 10.1016/j.pnpbp.2017.06.038. Epub 2017 Jul 5. Prog Neuropsychopharmacol Biol Psychiatry. 2018. PMID: 28689007 Review. No abstract available.
Protein-C Reactive as Biomarker Predictor of Schizophrenia Phases of Illness? A Systematic Review.
Orsolini L, Sarchione F, Vellante F, Fornaro M, Matarazzo I, Martinotti G, Valchera A, Di Nicola M, Carano A, Di Giannantonio M, Perna G, Olivieri L, De Berardis D. Orsolini L, et al. Among authors: vellante f. Curr Neuropharmacol. 2018;16(5):583-606. doi: 10.2174/1570159X16666180119144538. Curr Neuropharmacol. 2018. PMID: 29357805 Free PMC article. Review.
59 results